<DOC>
	<DOCNO>NCT01348308</DOCNO>
	<brief_summary>The objective OPTIMAL study demonstrate adjunction Maraviroc combination antiretroviral therapy naive late diagnose HIV-1 infected patient count may accelerate kinetics immune restoration decrease risk disease progression death . It randomize , versus placebo , double-blind trial , conduct France , Spain Italy .</brief_summary>
	<brief_title>Immuno-stimulation With Maraviroc Combined Antiretroviral Therapy Advanced Late Diagnosed HIV-1 Infected Patients</brief_title>
	<detailed_description />
	<mesh_term>Maraviroc</mesh_term>
	<mesh_term>Protease Inhibitors</mesh_term>
	<criteria>Confirmed HIV1 infection ( ELISA Western Blot test positive ) CD4+ T lymphocytes equal 200/mm続 previous AIDSdefiningillness diagnosis Patient na誰ve antiretroviral In woman , use contraceptive method , lack actual pregnancy Patients coverage social health After informed consent Current pregnancy , lack contraceptive method , breastfeed Current active tuberculosis ( either suspect , diagnose ) Ongoing malignancy except cutaneous Kaposi 's sarcoma . Patients previous cancer consider cure least 6 month could include study Current previous severe cardiac failure , chronic respiratory disease , renal liver insufficiency ; lifethreatening organ failure Cognitive impairment , psychiatric disorder , severe depressive affect , unadapted behavior Use cytostatic drug , immunosuppressive agent , steroid PMN ( polymorphonuclear neutrophil ) 750/mm続 , platelet 50,000/mm続 , haemoglobin 10 g/dL ; ASAT ( aspartate aminotransferase ) , ALAT ( alanine aminotransferase ) bilirubin 2.5 ULN ; lipase 2 ULN ( Upper limit normal ) , serum creatinine 1.5 ULN ; proteinuria 1g/L ; INR ( International Normalized Ratio ) abnormal Current previous , 3 last month , use immunomodulatory agent ( GCSF ( granulocyte colony stimulate factor ) , IL2 ( Interleukin2 ) , GMCSF ( Granulocyte Macrophage colony stimulate factor ) , interferon , pentoxifylline ) Hypersensitivity peanut /or soy product</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Late diagnose HIV-1 infected patient</keyword>
	<keyword>AIDS-defining event</keyword>
	<keyword>Immune restoration</keyword>
</DOC>